From the Lewis Katz School of Medicine at Temple University.
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Temple Health System, Lewis Katz School of Medicine, Philadelphia, PA.
Clin Nucl Med. 2022 Jan 1;47(1):79-80. doi: 10.1097/RLU.0000000000003825.
A 59-year-old woman with a history of papillary thyroid cancer status post total thyroidectomy and 131I ablation therapy presented with lower back pain and leg weakness. MRI of the lumbar spine revealed homogenously enhancing lesions at L1-L2 and L3-L4. Subsequent whole-body 123I-Na scan demonstrated significant 123I retention in the mid to distal esophagus, as well as diffuse uptake in basal segments of the lungs bilaterally. SPECT/CT of the lumbar vertebra was unremarkable. Although 123I-Na uptake often indicates metastatic recurrence, these findings were better explained by nonspecific radioiodine uptake secondary to systemic complications of the patient's underlying scleroderma.
一位 59 岁女性,有甲状腺乳头癌病史,已行甲状腺全切除术和 131I 消融治疗,因腰痛和下肢无力就诊。腰椎 MRI 显示 L1-L2 和 L3-L4 均匀强化病变。随后的全身 123I-Na 扫描显示中至远段食管有明显的 123I 滞留,双侧肺基底段有弥漫性摄取。腰椎 SPECT/CT 未见异常。尽管 123I-Na 摄取通常表明转移复发,但这些发现更可以用患者系统性硬皮病的全身并发症引起的非特异性放射性碘摄取来解释。